RENX.L LSE
Renalytix Plc
1W: -5.5%
1M: +40.0%
3M: +115.2%
YTD: +3.8%
1Y: -0.7%
3Y: -95.2%
5Y: -99.3%
£5.81 ($0.08)
-0.19 (-3.20%)
Weekly Expected Move ±17.2%
£4
£5
£6
£7
£8
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$18M
+40.6% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$18M
+40.6% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$1M
+94.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$36M | -$50M | -$46M | -$33M | -$22M |
| Depreciation & Amort. | $2M | $489K | $508K | $364K | $0 |
| Stock-Based Comp. | $2M | $5M | $3M | $2M | $3M |
| Change in Working Capital | $4M | -$2M | $5M | -$4M | -$3M |
| Other Non-Cash Items | -$495K | $1M | -$17K | $5M | $4M |
| Operating Cash Flow | -$25M | -$46M | -$34M | -$30M | -$18M |
| — Investing Activities — | |||||
| Capital Expenditures | -$2M | -$694K | $0 | -$4K | $0 |
| Acquisitions (Net) | $472K | $0 | $0 | $0 | $0 |
| Investment Purchases | -$1M | $0 | $0 | $0 | $0 |
| Investment Sales | $1M | $0 | $0 | $0 | $0 |
| Other Investing | $754K | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$741K | -$694K | $0 | -$4K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $18M | -$3M | -$2M | -$4M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$2M | -$991K | -$2M | $0 |
| Financing Cash Flow | $77M | $26M | $16M | $10M | $16M |
| Net Change in Cash | $52M | -$24M | -$17M | -$20M | -$1M |
| Cash End of Period | $65M | $41M | $25M | $5M | $4M |
| Free Cash Flow | -$26M | -$46M | -$33M | -$30M | -$18M |